Science
Psychedelics Show Promise in Combating Neurodegenerative Diseases
Research indicates that psychedelics like psilocybin may have potential to combat inflammation and protect against neurodegenerative diseases such as Parkinson's. Initial human data supports these findings, suggesting a new avenue for treatment development.
Coverage timeline — 1 article
NPR
Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.
2026-10-21 15:33 UTC